Cargando…
Defining Priorities to Improve Patient Experience in Non-Muscle Invasive Bladder Cancer
BACKGROUND: Although approximately 75% of bladder cancers are non-muscle invasive (NMIBC) at diagnosis, most research tends to focus on invasive disease (e.g., experiences related to radical cystectomy and urinary diversion). There is a lack of studies on quality of life, and especially qualitative...
Autores principales: | Garg, Tullika, Connors, Jill Nault, Ladd, Ilene G., Bogaczyk, Tyler L., Larson, Sharon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798497/ https://www.ncbi.nlm.nih.gov/pubmed/29430512 http://dx.doi.org/10.3233/BLC-170138 |
Ejemplares similares
-
Cost‐effectiveness of surveillance schedules in older adults with non‐muscle‐invasive bladder cancer
por: Heijnsdijk, Eveline A.M., et al.
Publicado: (2018) -
Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
por: Li, Jonathan, et al.
Publicado: (2021) -
p63 Expression Defines a Lethal Subset of Muscle-Invasive Bladder Cancers
por: Choi, Woonyoung, et al.
Publicado: (2012) -
Mutually exclusive mutation profiles define functionally related genes in muscle invasive bladder cancer
por: Sangster, Ami G., et al.
Publicado: (2022) -
Single Institutional Experience of Bladder-Preserving Trimodality Treatment for Muscle-Invasive Bladder Cancer
por: Joung, Jae Young, et al.
Publicado: (2008)